D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$436M |
| 2 |
AbbVie
ABBV
|
+$407M |
| 3 |
Johnson & Johnson
JNJ
|
+$295M |
| 4 |
Gilead Sciences
GILD
|
+$267M |
| 5 |
Starbucks
SBUX
|
+$230M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$407M |
| 2 |
Booking.com
BKNG
|
+$400M |
| 3 |
Citigroup
C
|
+$314M |
| 4 |
SHPG
Shire pic
SHPG
|
+$276M |
| 5 |
PayPal
PYPL
|
+$257M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.47% |
| 2 | Consumer Discretionary | 13.31% |
| 3 | Healthcare | 13.17% |
| 4 | Financials | 7.14% |
| 5 | Industrials | 6.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HZNP
151
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $116M | 0.15% |
4,401,979
+1,032,471
| +31% | +$24.5M |
|
152
Advanced Micro Devices
AMD
$851B
| $116M | 0.15% |
4,556,449
+1,855,536
| +69% | +$42.1M |
|
|
NVRO
153
DELISTED
NEVRO CORP.
NVRO
| $116M | 0.15% |
1,850,720
+534,630
| +41% | +$25.1M |
|
154
PUT
CVS Health
CVS
$137B
| $115M | 0.15% |
2,132,550
+1,208,301
| +131% | +$74.6M |
|
155
HP
HPQ
$23.5B
| $115M | 0.15% |
5,918,920
+3,150,098
| +114% | +$66.8M |
|
156
PVH
PVH
$3.71B
| $115M | 0.15% |
940,454
-665,088
| -41% | -$72.8M |
|
|
MRO
157
DELISTED
Marathon Oil Corporation
MRO
| $114M | 0.15% |
6,848,071
+4,291,748
| +168% | +$70.1M |
|
158
PUT
Baidu
BIDU
$35.8B
| $114M | 0.15% |
691,900
-142,300
| -17% | -$23.8M |
|
159
Howmet Aerospace
HWM
$116B
| $114M | 0.15% |
7,781,115
-492,878
| -6% | -$7.06M |
|
160
PUT
SLB Ltd
SLB
$78.4B
| $114M | 0.15% |
2,616,200
+148,300
| +6% | +$6.41M |
|
161
CALL
Meta Platforms (Facebook)
META
$1.51T
| $114M | 0.15% |
682,200
+352,200
| +107% | +$56M |
|
162
Automatic Data Processing
ADP
$100B
| $113M | 0.15% |
707,463
-1,093,791
| -61% | -$159M |
|
163
Berkshire Hathaway Class B
BRK.B
$1.07T
| $112M | 0.14% |
556,890
+392,036
| +238% | +$79.1M |
|
164
Target
TGT
$62.1B
| $112M | 0.14% |
1,389,524
+524,052
| +61% | +$38.3M |
|
165
Gen Digital
GEN
$15.6B
| $110M | 0.14% |
4,782,370
-370,126
| -7% | -$8.06M |
|
|
MNK
166
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $110M | 0.14% |
5,040,137
+513,803
| +11% | +$11M |
|
167
EOG Resources
EOG
$78B
| $109M | 0.14% |
1,142,542
+1,043,549
| +1,054% | +$99.4M |
|
|
CLR
168
DELISTED
CONTINENTAL RESOURCES INC.
CLR
| $109M | 0.14% |
2,424,864
+898,296
| +59% | +$40.2M |
|
169
Trip.com Group
TCOM
$27.5B
| $108M | 0.14% |
2,474,357
+2,215,054
| +854% | +$77.7M |
|
170
Micron Technology
MU
$1.04T
| $107M | 0.14% |
2,589,056
-5,397,838
| -68% | -$209M |
|
171
PUT
Wells Fargo
WFC
$261B
| $106M | 0.14% |
2,191,800
-1,152,100
| -34% | -$56.7M |
|
172
Eli Lilly
LLY
$1.07T
| $106M | 0.14% |
813,824
-380,469
| -32% | -$46.3M |
|
|
173
PUT
Advanced Micro Devices
AMD
$851B
| $105M | 0.14% |
4,127,400
-3,096,500
| -43% | -$70.3M |
|
174
Bank of America
BAC
$435B
| $105M | 0.14% |
3,807,938
+2,589,982
| +213% | +$73.2M |
|
|
SIX
175
DELISTED
Six Flags Entertainment Corp.
SIX
| $105M | 0.14% |
2,118,849
+873,056
| +70% | +$49.4M |
|
Similar funds
D.E. Shaw & Co's Q1 2019 Portfolio in Review
As of Q1 2019, D.E. Shaw & Co held 4,169 positions worth $77.4B, up 6.6% from $72.6B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
D.E. Shaw & Co withdrew a net $6.74B in Q1 2019, closing 617 positions and reducing 1,599 holdings. Its most notable exit was Shire pic, an estimated $276M position sold in full.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, D.E. Shaw & Co opened a new position in Lyft worth $159M.
- D.E. Shaw & Co's largest Q1 2019 buy was Lyft: 2,245,851 shares worth $159M.
- D.E. Shaw & Co added most to Pfizer in Q1 2019, an estimated $436M increase.
- D.E. Shaw & Co's biggest Q1 2019 reduction was Bristol-Myers Squibb, cutting an estimated $407M.
- D.E. Shaw & Co fully exited Shire pic in Q1 2019, selling an estimated $276M.
- D.E. Shaw & Co's ten largest holdings make up 9% of its $77.4B portfolio in Q1 2019.
- D.E. Shaw & Co opened 447 new positions and closed 617 in Q1 2019.
- D.E. Shaw & Co's portfolio value rose 6.6% quarter-over-quarter to $77.4B.
Based on D.E. Shaw & Co's 13F filing for Q1 2019, filed 15 May 2019.